Daiichi Sankyo Co., Ltd. is a prominent pharmaceutical company based in Japan, specializing in the research, development, and manufacturing of pharmaceutical products. The company's primary focus is o... Daiichi Sankyo Co., Ltd. is a prominent pharmaceutical company based in Japan, specializing in the research, development, and manufacturing of pharmaceutical products. The company's primary focus is on developing innovative treatments across several critical therapeutic areas such as oncology, cardiovascular diseases, and rare genetic conditions. Notable for its robust pipeline of drugs, Daiichi Sankyo aims to leverage cutting-edge science in antibody-drug conjugates and other novel drug delivery systems to provide advanced treatments for unmet medical needs. As a key player in the global pharmaceutical industry, Daiichi Sankyo impacts multiple sectors, including healthcare services and biotechnology. Its strategic collaborations with other leading global pharmaceutical companies further enhance its growth prospects and innovation capabilities. Headquartered in Tokyo, Japan, and with a broad international footprint, Daiichi Sankyo holds significant market significance. It plays a vital role in advancing global healthcare solutions, ensuring a pipeline of emerging therapies can address future challenges in medical treatment.Show lessShow more

Disclosures ESG Data Financial Data

Income Statement Balance Sheet Group Entities

Data not available

Group Entities data not yet covered for Daiichi Sankyo

We have not yet reviewed Daiichi Sankyo's disclosures for Group Entities data.

If this data is relevant to your work, you can submit a data coverage request and our team will investigate the company's disclosures and capture the data if available.

Would you like us to review Daiichi Sankyo's data?

Create a free Tracenable account to signal interest in having our team review data for Daiichi Sankyo.

Legal Center Contact Us